Isolated antineutrophil cytoplasmic antibody-associated interstitial lung disease is an increasingly recognized fibrotic ILD phenotype.

The growing interstitial lung disease market is supported by the widespread use of foundational and supportive treatments such as corticosteroids, immunosuppressants, biologics, and adjunct therapies ...

A lower initial lung diffusion capacity for carbon monoxide is associated with a higher rate of progression from very early diagnosis to definite systemic sclerosis.

Specific combinations of CT imaging features rather than individual findings alone may improve the accuracy of identifying ...

SAQE, an innovative tool achieving over 90% accuracy in diagnosing Hypersensitivity Pneumonitis, a serious lung condition ...

SAQE, a tool with over 90% accuracy for diagnosing Hypersensitivity Pneumonitis. This lung condition, prevalent in South Asia, leads to fibrosis. The tool uses a questionnaire to assess environmental ...

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...

This press release shall not constitute an offer to sell, or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...

Interstitial lung disease is a disease characterised by basic pathology of inflammation and fibrosis. Any kind of trigger most common being smoke, dust, organic & inorganic dust exposure, mold can ...

Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its ...

AllRock Bio has dosed the first patients in the Phase IIa ROCSTAR clinical trial investigating ROC-101, an oral ...

Trevi Therapeutics Investor and Analyst Day May 7, 2026, Midtown New York, New York 10:00 a.m. to 12:00 p.m. ET Representatives: Trevi senior management will be joined by key opinion leaders in ...